{"id":72851,"date":"2023-07-25T05:56:58","date_gmt":"2023-07-25T03:56:58","guid":{"rendered":"https:\/\/www.fedaiisf.it\/?p=72851"},"modified":"2023-08-12T18:24:35","modified_gmt":"2023-08-12T16:24:35","slug":"linee-guida-sulla-pubblicita-sanitaria-dei-medicinali-di-automedicazione-otc-e-dei-medicinali-senza-obbligo-di-prescrizione-sop","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/linee-guida-sulla-pubblicita-sanitaria-dei-medicinali-di-automedicazione-otc-e-dei-medicinali-senza-obbligo-di-prescrizione-sop\/","title":{"rendered":"Guidelines on health advertising of over-the-counter medicines (OTC) and non-prescription medicines (SOP)"},"content":{"rendered":"<p><span style=\"font-size: 14pt;\">The new ones have been published <a href=\"https:\/\/www.salute.gov.it\/imgs\/C_17_pubblicazioni_3344_allegato.pdf\" target=\"_blank\" rel=\"noopener\">Guidelines on health advertising of over-the-counter medicines (OTC) and non-prescription medicines (SOP)<\/a> which provide clarifications regarding the methods permitted for the dissemination of advertising messages, with <img loading=\"lazy\" decoding=\"async\" class=\"wp-image-72854 alignright\" src=\"https:\/\/www.fedaiisf.it\/wp-content\/uploads\/2023\/07\/informazione-medico-scientifica-.png\" alt=\"\" width=\"550\" height=\"288\" srcset=\"https:\/\/www.fedaiisf.it\/wp-content\/uploads\/2023\/07\/informazione-medico-scientifica-.png 1052w, https:\/\/www.fedaiisf.it\/wp-content\/uploads\/2023\/07\/informazione-medico-scientifica--300x157.png 300w, https:\/\/www.fedaiisf.it\/wp-content\/uploads\/2023\/07\/informazione-medico-scientifica--1024x536.png 1024w, https:\/\/www.fedaiisf.it\/wp-content\/uploads\/2023\/07\/informazione-medico-scientifica--768x402.png 768w, https:\/\/www.fedaiisf.it\/wp-content\/uploads\/2023\/07\/informazione-medico-scientifica--18x9.png 18w\" sizes=\"auto, (max-width: 550px) 100vw, 550px\" \/>particular reference to the use of new communication channels.<\/span><\/p>\n<p><span style=\"font-size: 14pt;\">The document, approved by the Health Advertising Licensing Section of the Health Technical Committee, updates and replaces the previous Guidelines published in recent years for medicines. <\/span><\/p>\n<p><span style=\"font-size: 14pt;\">The reference regulatory framework for the advertising of medicinal products remains unchanged, defined by Legislative Decree 219\/2006 which identifies fundamental principles, limits, characteristics, minimum content and prohibited content and regulates the procedure for authorizing messages by the Ministry. <\/span><\/p>\n<p><span style=\"font-size: 14pt;\">A tool, therefore, developed with the aim of facilitating the activity of professional operators which, at the same time, guarantees the protection of health.<\/span><\/p>\n<p><span style=\"font-size: 14pt;\">Were also updated i <a href=\"https:\/\/www.salute.gov.it\/portale\/moduliServizi\/dettaglioSchedaModuliServizi.jsp?lingua=italiano&amp;menu=tema&amp;label=servizionline&amp;tema=MED&amp;idMat=MED&amp;idAmb=PUB&amp;idSrv=A01&amp;flag=P&amp;gruppoTema=ALL\" target=\"_blank\" rel=\"noopener\">forms<\/a> to submit applications for authorization which can be sent, with the relative attachments, exclusively via pec.<\/span><\/p>\n<div>\n<p><strong>Consult the <a tabindex=\"54\" title=\"Link to the news of the Pharmaceutical Service thematic area\" href=\"https:\/\/www.salute.gov.it\/portale\/news\/p3_2_1.jsp?lingua=italiano&amp;menu=notizie&amp;area=farmaci&amp;btnCerca=\" target=\"_blank\" rel=\"noopener\">Pharmaceutical service news<\/a><\/strong><\/p>\n<\/div>\n<p><a href=\"https:\/\/www.salute.gov.it\/portale\/news\/p3_2_1_1_1.jsp?lingua=italiano&amp;menu=notizie&amp;p=dalministero&amp;id=6313\" target=\"_blank\" rel=\"noopener\">Ministry of Health \u2013 21 July 2023<\/a><\/p>\n<hr \/>\n<p>Related news: <a href=\"https:\/\/www.fedaiisf.it\/en\/sentenza-corte-europea-la-pubblicita-sui-medicinali-e-subordinata-a-condizioni-restrizioni-e-divieti-allo-scopo-di-assicurare-la-tutela-della-sanita-pubblica\/\" target=\"_blank\" rel=\"noopener\">Judgment of the European Court. Advertising of medicines is subject to conditions, restrictions and bans in order to ensure the protection of public health. The advertising promotion of medicines on the basis of the price is contrary to EU law<\/a><\/p>\n<p><a href=\"https:\/\/sites.unimi.it\/gazzalab\/wordpress\/wp-content\/uploads\/2011\/12\/23-La-Pubblicit\u00e0-dei-Medicinali.pdf\" target=\"_blank\" rel=\"noopener\">Advertising of medicines: scientific information and advertising to the public<\/a><\/p>\n<p>&nbsp;<\/p>","protected":false},"excerpt":{"rendered":"<p>Sono state pubblicate le nuove Linee guida sulla pubblicit\u00e0 sanitaria dei medicinali di automedicazione (OTC) e dei medicinali senza obbligo di prescrizione (SOP) che forniscono chiarimenti in merito alle modalit\u00e0 consentite per la diffusione dei messaggi pubblicitari, con particolare riferimento all\u2019utilizzo dei nuovi canali di comunicazione. Il documento, approvato dalla Sezione per il rilascio delle &hellip;<\/p>","protected":false},"author":4,"featured_media":33593,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[16],"tags":[41],"class_list":["post-72851","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-primo-piano","tag-leggisentenze"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/72851","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=72851"}],"version-history":[{"count":4,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/72851\/revisions"}],"predecessor-version":[{"id":72856,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/72851\/revisions\/72856"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/33593"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=72851"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=72851"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=72851"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}